BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 26971948)

  • 1. Psychiatric Risk Gene Transcription Factor 4 Regulates Intrinsic Excitability of Prefrontal Neurons via Repression of SCN10a and KCNQ1.
    Rannals MD; Hamersky GR; Page SC; Campbell MN; Briley A; Gallo RA; Phan BN; Hyde TM; Kleinman JE; Shin JH; Jaffe AE; Weinberger DR; Maher BJ
    Neuron; 2016 Apr; 90(1):43-55. PubMed ID: 26971948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disordered breathing in a Pitt-Hopkins syndrome model involves Phox2b-expressing parafacial neurons and aberrant Nav1.8 expression.
    Cleary CM; James S; Maher BJ; Mulkey DK
    Nat Commun; 2021 Oct; 12(1):5962. PubMed ID: 34645823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodevelopmental models of transcription factor 4 deficiency converge on a common ion channel as a potential therapeutic target for Pitt Hopkins syndrome.
    Rannals MD; Page SC; Campbell MN; Gallo RA; Mayfield B; Maher BJ
    Rare Dis; 2016; 4(1):e1220468. PubMed ID: 28032012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional analysis of TCF4 missense mutations that cause Pitt-Hopkins syndrome.
    Forrest M; Chapman RM; Doyle AM; Tinsley CL; Waite A; Blake DJ
    Hum Mutat; 2012 Dec; 33(12):1676-86. PubMed ID: 22777675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pitt-Hopkins syndrome-associated mutations in TCF4 lead to variable impairment of the transcription factor function ranging from hypomorphic to dominant-negative effects.
    Sepp M; Pruunsild P; Timmusk T
    Hum Mol Genet; 2012 Jul; 21(13):2873-88. PubMed ID: 22460224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel comprehensive diagnostic strategy in Pitt-Hopkins syndrome: clinical score and further delineation of the TCF4 mutational spectrum.
    Whalen S; Héron D; Gaillon T; Moldovan O; Rossi M; Devillard F; Giuliano F; Soares G; Mathieu-Dramard M; Afenjar A; Charles P; Mignot C; Burglen L; Van Maldergem L; Piard J; Aftimos S; Mancini G; Dias P; Philip N; Goldenberg A; Le Merrer M; Rio M; Josifova D; Van Hagen JM; Lacombe D; Edery P; Dupuis-Girod S; Putoux A; Sanlaville D; Fischer R; Drévillon L; Briand-Suleau A; Metay C; Goossens M; Amiel J; Jacquette A; Giurgea I
    Hum Mutat; 2012 Jan; 33(1):64-72. PubMed ID: 22045651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pitt-Hopkins Syndrome: intellectual disability due to loss of TCF4-regulated gene transcription.
    Sweatt JD
    Exp Mol Med; 2013 May; 45(5):e21. PubMed ID: 23640545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Na
    Martinowich K; Das D; Sripathy SR; Mai Y; Kenney RF; Maher BJ
    Mol Psychiatry; 2023 Jan; 28(1):76-82. PubMed ID: 36224259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the expression pattern of the schizophrenia-risk and intellectual disability gene TCF4 in the developing and adult brain suggests a role in development and plasticity of cortical and hippocampal neurons.
    Jung M; Häberle BM; Tschaikowsky T; Wittmann MT; Balta EA; Stadler VC; Zweier C; Dörfler A; Gloeckner CJ; Lie DC
    Mol Autism; 2018; 9():20. PubMed ID: 29588831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial deletion of TCF4 in three generation family with non-syndromic intellectual disability, without features of Pitt-Hopkins syndrome.
    Kharbanda M; Kannike K; Lampe A; Berg J; Timmusk T; Sepp M
    Eur J Med Genet; 2016 Jun; 59(6-7):310-4. PubMed ID: 27132474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emerging roles of TCF4 in disease and development.
    Forrest MP; Hill MJ; Quantock AJ; Martin-Rendon E; Blake DJ
    Trends Mol Med; 2014 Jun; 20(6):322-31. PubMed ID: 24594265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Pitt-Hopkins syndrome: report of 16 new patients and clinical diagnostic criteria.
    Marangi G; Ricciardi S; Orteschi D; Lattante S; Murdolo M; Dallapiccola B; Biscione C; Lecce R; Chiurazzi P; Romano C; Greco D; Pettinato R; Sorge G; Pantaleoni C; Alfei E; Toldo I; Magnani C; Bonanni P; Martinez F; Serra G; Battaglia D; Lettori D; Vasco G; Baroncini A; Daolio C; Zollino M
    Am J Med Genet A; 2011 Jul; 155A(7):1536-45. PubMed ID: 21671391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic mosaicism in a mother of two children with Pitt-Hopkins syndrome.
    Steinbusch CV; van Roozendaal KE; Tserpelis D; Smeets EE; Kranenburg-de Koning TJ; de Waal KH; Zweier C; Rauch A; Hennekam RC; Blok MJ; Schrander-Stumpel CT
    Clin Genet; 2013 Jan; 83(1):73-7. PubMed ID: 22335494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of Pitt-Hopkins syndrome with absence of hyperventilation.
    Inati A; Abbas HA; Korjian S; Daaboul Y; Harajeily M; Saab R
    J Child Neurol; 2013 Dec; 28(12):1698-701. PubMed ID: 23248353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 263.4 kb deletion within the TCF4 gene consistent with Pitt-Hopkins syndrome, inherited from a mosaic parent with normal phenotype.
    Kousoulidou L; Tanteles G; Moutafi M; Sismani C; Patsalis PC; Anastasiadou V
    Eur J Med Genet; 2013 Jun; 56(6):314-8. PubMed ID: 23528641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mosaic 18q21.2 deletions including the TCF4 gene: a clinical report.
    Rossi M; Labalme A; Cordier MP; Till M; Blanchard G; Dubois R; Guibaud L; Heissat S; Javouhey E; Lachaux A; Mure PY; Ville D; Edery P; Sanlaville D
    Am J Med Genet A; 2012 Dec; 158A(12):3174-81. PubMed ID: 23165966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repurposing the Dihydropyridine Calcium Channel Inhibitor Nicardipine as a Na
    Ekins S; Puhl AC; Davidow A
    Pharm Res; 2020 Jun; 37(7):127. PubMed ID: 32529312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex translocation disrupting TCF4 and altering TCF4 isoform expression segregates as mild autosomal dominant intellectual disability.
    Maduro V; Pusey BN; Cherukuri PF; Atkins P; du Souich C; Rupps R; Limbos M; Adams DR; Bhatt SS; Eydoux P; Links AE; Lehman A; Malicdan MC; Mason CE; Morimoto M; Mullikin JC; Sear A; Van Karnebeek C; Stankiewicz P; Gahl WA; Toro C; Boerkoel CF
    Orphanet J Rare Dis; 2016 May; 11(1):62. PubMed ID: 27179618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common Pathophysiology in Multiple Mouse Models of Pitt-Hopkins Syndrome.
    Thaxton C; Kloth AD; Clark EP; Moy SS; Chitwood RA; Philpot BD
    J Neurosci; 2018 Jan; 38(4):918-936. PubMed ID: 29222403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing Approved Drugs as Inhibitors of K
    Ekins S; Gerlach J; Zorn KM; Antonio BM; Lin Z; Gerlach A
    Pharm Res; 2019 Jul; 36(9):137. PubMed ID: 31332533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.